RTW INVESTMENTS, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (SAGE)

Filing Manager: RTW INVESTMENTS, LP
Reporting Manager: RTW Investments, LP
Security: Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: SAGE
Shares outstanding: 61.3M shares
Disclosed Ownership: 3M shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 09:00:03 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
RTW Investments, LP	4.9%	3M	0	3M	/s/ Roderick Wong, M.D	Roderick Wong, M.D., Managing Partner
Roderick Wong, M.D.	4.9%	3M	0	3M	/s/ Roderick Wong, M.D	Roderick Wong, M.D